Skip to main content
Top
Published in: Critical Care 4/2008

Open Access 01-08-2008 | Research

Procalcitonin in liver transplantation: are high levels due to donors or recipients?

Authors: Daniel Eyraud, Saïd Ben Ayed, Marie Laure Tanguy, Corinne Vézinet, Jean Michel Siksik, Maguy Bernard, Sylvia Fratéa, Marie Movschin, Jean-Christophe Vaillant, Pierre Coriat, Laurent Hannoun

Published in: Critical Care | Issue 4/2008

Login to get access

Abstract

Introduction

To date, a specific marker to evaluate and predict the clinical course or complication of the liver-transplanted patient is not available in clinical practice. Increased procalcitonin (PCT) levels have been found in infectious inflammation; poor organ perfusion and high PCT levels in the cardiac donor appeared to predict early graft failure. We evaluated PCT as a predictor of early graft dysfunction and postoperative complications.

Methods

PCT serum concentrations were measured in samples collected before organ retrieval from 67 consecutive brain-dead donors and in corresponding recipients from day 0, before liver transplantation, up to day 7 after liver transplantation. The following parameters were recorded in donors: amount of vasopressive drug doses, cardiac arrest history 24 hours before retrieval, number of days in the intensive care unit, age of donor, and infection in donor, and the following parameters were recorded in recipients: cold and warm ischemia time, veno-venous bypass, transfusion amount during orthotopic liver transplantation (OLT), and occurrence of postoperative complication or hepatic dysfunction.

Results

In the donor, the preoperative level of PCT was associated with cardiac arrest and high doses of catecholamines before organ retrieval. In the recipient, elevated PCT levels were observed early after OLT, with a peak at day 1 or 2 after OLT, then a decrease until day 7. A postoperative peak of PCT levels was associated neither with preoperative PCT levels in the donor or the recipients nor with hepatic post-OLT dysfunction or other postoperative complications, but with two donor parameters: infection and cardiac arrest.

Conclusion

PCT level in the donor and early PCT peak in the recipient are not predictive of post-OLT hepatic dysfunction or other complications. Cardiac arrest and infection in the donor, but not PCT level in the donor, are associated with high post-OLT PCT levels in the recipient.
Appendix
Available only for authorised users
Literature
1.
go back to reference Morgenthaler NG, Struck J, Chancerelle Y, Weglohner W, Agay D, Bohuon C, Suarez-Domenech V, Bergmann A, Muller B: Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection. Horm Metab Res. 2003, 35: 290-295. 10.1055/s-2003-41304.CrossRefPubMed Morgenthaler NG, Struck J, Chancerelle Y, Weglohner W, Agay D, Bohuon C, Suarez-Domenech V, Bergmann A, Muller B: Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection. Horm Metab Res. 2003, 35: 290-295. 10.1055/s-2003-41304.CrossRefPubMed
2.
go back to reference Meisner M, Tschaikowsky K, Schmidt J, Schüttler J: Procalcitonin (PCT)-indications for a new diagnostic parameter of severe bacterial infection and sepsis in transplantation, immunosuppression and cardiac assist devices. Cardiovascular Engineering. 1996, 1: 67-76. Meisner M, Tschaikowsky K, Schmidt J, Schüttler J: Procalcitonin (PCT)-indications for a new diagnostic parameter of severe bacterial infection and sepsis in transplantation, immunosuppression and cardiac assist devices. Cardiovascular Engineering. 1996, 1: 67-76.
3.
go back to reference Brunkhorst FM, Heinz U, Forycki ZF: Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med. 1998, 24: 888-889. 10.1007/s001340050683.CrossRefPubMed Brunkhorst FM, Heinz U, Forycki ZF: Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med. 1998, 24: 888-889. 10.1007/s001340050683.CrossRefPubMed
4.
go back to reference Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993, 341: 515-518. 10.1016/0140-6736(93)90277-N.CrossRefPubMed Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993, 341: 515-518. 10.1016/0140-6736(93)90277-N.CrossRefPubMed
5.
go back to reference Kuse ER, Langefeld I, Jaeger K, Külpmann WR: Procalcitonine in fever of unknown origin after liver transplantation: a variable to differentiate acute rejection from infection. Crit Care Med. 2000, 28: 555-559. 10.1097/00003246-200002000-00044.CrossRefPubMed Kuse ER, Langefeld I, Jaeger K, Külpmann WR: Procalcitonine in fever of unknown origin after liver transplantation: a variable to differentiate acute rejection from infection. Crit Care Med. 2000, 28: 555-559. 10.1097/00003246-200002000-00044.CrossRefPubMed
6.
go back to reference Kunz D, Pross M, König W, Lippert H, Manger T: Diagnostic relevance of procalcitonin, IL-6 and cellular immune status in the early phase after liver transplantation. Transplant Proc. 1998, 30: 2398-2399. 10.1016/S0041-1345(98)00667-8.CrossRefPubMed Kunz D, Pross M, König W, Lippert H, Manger T: Diagnostic relevance of procalcitonin, IL-6 and cellular immune status in the early phase after liver transplantation. Transplant Proc. 1998, 30: 2398-2399. 10.1016/S0041-1345(98)00667-8.CrossRefPubMed
7.
go back to reference Ploeg RJ, D'Alessandro A, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, Sasaki T, Sollinger HW, Belzer FO, Kalayoglu M: Risk factors for primary dysfunction after liver transplantation – a multivariate analysis. Transplantation. 1993, 55: 807-813. 10.1097/00007890-199304000-00024.CrossRefPubMed Ploeg RJ, D'Alessandro A, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, Sasaki T, Sollinger HW, Belzer FO, Kalayoglu M: Risk factors for primary dysfunction after liver transplantation – a multivariate analysis. Transplantation. 1993, 55: 807-813. 10.1097/00007890-199304000-00024.CrossRefPubMed
8.
go back to reference Fazakas J, Toth S, Varga M, Svari E, Kobori L: The procalcitonin level changes after liver transplantation according to the graft flushing technique used. ILTS Milan 2006 May 3. Liver Transpl. 2006, A48-suppl Fazakas J, Toth S, Varga M, Svari E, Kobori L: The procalcitonin level changes after liver transplantation according to the graft flushing technique used. ILTS Milan 2006 May 3. Liver Transpl. 2006, A48-suppl
9.
go back to reference Elefsiniotis IS, Skounakis M, Vezali E, Pantazis KD, Petrocheilou A, Pirounaki M, Papatsibas G, Kontou-Kastellanou C, Moulakakis A: Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease. Eur J Gastroenterol Hepatol. 2006, 18: 525-530. 10.1097/00042737-200605000-00012.CrossRefPubMed Elefsiniotis IS, Skounakis M, Vezali E, Pantazis KD, Petrocheilou A, Pirounaki M, Papatsibas G, Kontou-Kastellanou C, Moulakakis A: Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease. Eur J Gastroenterol Hepatol. 2006, 18: 525-530. 10.1097/00042737-200605000-00012.CrossRefPubMed
10.
go back to reference Connert S, Stremmel W, Elsin C: Procalcitonin is a valid marker of infection in decompensated cirrhosis. Z Gastroenterol. 2003, 41: 165-170. 10.1055/s-2003-37314.CrossRefPubMed Connert S, Stremmel W, Elsin C: Procalcitonin is a valid marker of infection in decompensated cirrhosis. Z Gastroenterol. 2003, 41: 165-170. 10.1055/s-2003-37314.CrossRefPubMed
11.
go back to reference Bota DP, Van Nuffelen M, Zakariah AN, Vincent JL: Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. J Lab Clin Med. 2005, 146: 347-351. 10.1016/j.lab.2005.08.005.CrossRefPubMed Bota DP, Van Nuffelen M, Zakariah AN, Vincent JL: Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. J Lab Clin Med. 2005, 146: 347-351. 10.1016/j.lab.2005.08.005.CrossRefPubMed
12.
go back to reference Fazakas J, Gondos T, Varga M, Sarvary E, Hrovitz P, Perner F: Analysis of systemic and regional procalcitonin serum levels during liver transplantation. Transpl Int. 2003, 16: 465-470. 10.1111/j.1432-2277.2003.tb00334.x.CrossRefPubMed Fazakas J, Gondos T, Varga M, Sarvary E, Hrovitz P, Perner F: Analysis of systemic and regional procalcitonin serum levels during liver transplantation. Transpl Int. 2003, 16: 465-470. 10.1111/j.1432-2277.2003.tb00334.x.CrossRefPubMed
13.
go back to reference Busuttil RW, Tanaka K: The utility of marginal donors in liver transplantation. Liver Transpl. 2003, 9: 651-663. 10.1053/jlts.2003.50105.CrossRefPubMed Busuttil RW, Tanaka K: The utility of marginal donors in liver transplantation. Liver Transpl. 2003, 9: 651-663. 10.1053/jlts.2003.50105.CrossRefPubMed
14.
go back to reference Wagner FD, Jonitz B, Potapov EV, Qedra N, Wegscheider K, Abraham K, Ivanitskaia EA, Loebe M, Hetzer R: Procalcitonin, a donor-specific predictor of early graft failure-related mortality after heart transplantation. Circulation. 2001, 104 (): I192-I196. 10.1161/hc37t1.094836.CrossRefPubMed Wagner FD, Jonitz B, Potapov EV, Qedra N, Wegscheider K, Abraham K, Ivanitskaia EA, Loebe M, Hetzer R: Procalcitonin, a donor-specific predictor of early graft failure-related mortality after heart transplantation. Circulation. 2001, 104 (): I192-I196. 10.1161/hc37t1.094836.CrossRefPubMed
15.
go back to reference Potapov EV, Wagner FD, Loebe M, Ivanitskaia EA, Müller C, Sodian R, Jonitz B, Hetzer R: Elevated donor cardiac troponin T and procalcitonin indicate two independent mechanisms of early graft failure after heart transplantation. Int J Cardiol. 2003, 92: 163-167. 10.1016/S0167-5273(03)00083-4.CrossRefPubMed Potapov EV, Wagner FD, Loebe M, Ivanitskaia EA, Müller C, Sodian R, Jonitz B, Hetzer R: Elevated donor cardiac troponin T and procalcitonin indicate two independent mechanisms of early graft failure after heart transplantation. Int J Cardiol. 2003, 92: 163-167. 10.1016/S0167-5273(03)00083-4.CrossRefPubMed
16.
go back to reference Karzaï W, Oberhoffer M, Meier-Hellmann A, Reinhart K: Procalcitonin: a new indicator of the systemic response to sever infections. Infection. 1997, 25: 329-334. 10.1007/BF01740811.CrossRefPubMed Karzaï W, Oberhoffer M, Meier-Hellmann A, Reinhart K: Procalcitonin: a new indicator of the systemic response to sever infections. Infection. 1997, 25: 329-334. 10.1007/BF01740811.CrossRefPubMed
17.
go back to reference Meisner M, Adina H, Schmidt J: Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care. 2006, 10: R1-10.1186/cc3910.PubMedCentralCrossRefPubMed Meisner M, Adina H, Schmidt J: Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care. 2006, 10: R1-10.1186/cc3910.PubMedCentralCrossRefPubMed
18.
go back to reference Gendrel D, Raymond J, Assicot M, Moulin F, Iniquez JL, Lebon P, Bohuon C: Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis. 1997, 24: 1240-1242. 10.1086/513633.CrossRefPubMed Gendrel D, Raymond J, Assicot M, Moulin F, Iniquez JL, Lebon P, Bohuon C: Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis. 1997, 24: 1240-1242. 10.1086/513633.CrossRefPubMed
19.
go back to reference Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Müller B: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trail. Lancet. 2004, 363: 600-607. 10.1016/S0140-6736(04)15591-8.CrossRefPubMed Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Müller B: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trail. Lancet. 2004, 363: 600-607. 10.1016/S0140-6736(04)15591-8.CrossRefPubMed
20.
go back to reference Nylen ES, Whang KT, Snider RH, Steinwald PM, White JC, Becker KL: Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med. 1998, 26: 1001-1006. 10.1097/00003246-199806000-00015.CrossRefPubMed Nylen ES, Whang KT, Snider RH, Steinwald PM, White JC, Becker KL: Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med. 1998, 26: 1001-1006. 10.1097/00003246-199806000-00015.CrossRefPubMed
21.
go back to reference Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C: Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994, 79: 1605-1608. 10.1210/jc.79.6.1605.PubMed Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C: Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994, 79: 1605-1608. 10.1210/jc.79.6.1605.PubMed
22.
go back to reference Brunkhorst FM, Clark AL, Forycki ZF, Anker SD, Feyrer R: Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation. Int J Cardiol. 1999, 72: 3-10. 10.1016/S0167-5273(99)00118-7.CrossRefPubMed Brunkhorst FM, Clark AL, Forycki ZF, Anker SD, Feyrer R: Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation. Int J Cardiol. 1999, 72: 3-10. 10.1016/S0167-5273(99)00118-7.CrossRefPubMed
23.
go back to reference Sabat R, Höflich C, Döcke WD, Oppert M, Kern F, Windrich B, Rosenberger C, Kaden J, Volk HD, Reinke P: Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies. Intensive Care Med. 2001, 27: 987-991. 10.1007/s001340100949.CrossRefPubMed Sabat R, Höflich C, Döcke WD, Oppert M, Kern F, Windrich B, Rosenberger C, Kaden J, Volk HD, Reinke P: Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies. Intensive Care Med. 2001, 27: 987-991. 10.1007/s001340100949.CrossRefPubMed
24.
go back to reference Zazula R, Prucha M, Tyll T, Kieslichova E: Induction of procalcitonin in liver transplants treated with anti-thymocyte globulin. Crit Care. 2007, 11: R131-10.1186/cc6202.PubMedCentralCrossRefPubMed Zazula R, Prucha M, Tyll T, Kieslichova E: Induction of procalcitonin in liver transplants treated with anti-thymocyte globulin. Crit Care. 2007, 11: R131-10.1186/cc6202.PubMedCentralCrossRefPubMed
25.
go back to reference Meisner M, Raushmayer C, Schmidt J, Feyrer R, Cesnjevar R, Bredle D, Tschaïkowsky K: Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complication. Inensive Care Med. 2002, 28: 1094-1102. 10.1007/s00134-002-1392-5.CrossRef Meisner M, Raushmayer C, Schmidt J, Feyrer R, Cesnjevar R, Bredle D, Tschaïkowsky K: Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complication. Inensive Care Med. 2002, 28: 1094-1102. 10.1007/s00134-002-1392-5.CrossRef
26.
go back to reference Lecharny JB, Khater D, Bronchard R, Philip I, Durand G, Desmonts JM, Dehoux M: Hyperprocalcitoninemia in patients with perioperative myocardial infarction after cardiac surgery. Crit Care Med. 2001, 29: 323-325. 10.1097/00003246-200102000-00019.CrossRefPubMed Lecharny JB, Khater D, Bronchard R, Philip I, Durand G, Desmonts JM, Dehoux M: Hyperprocalcitoninemia in patients with perioperative myocardial infarction after cardiac surgery. Crit Care Med. 2001, 29: 323-325. 10.1097/00003246-200102000-00019.CrossRefPubMed
27.
go back to reference Aouifi A, Piriou V, Bastien O, Blanc P, Bouvier H, Evans R, Celard M, Vandenesch F, Rousson R, Lehot JJ: Usefulness of procalciton for diagnosis of infection in cardiac surgical patients. Crit Care Med. 2000, 28: 3171-3176. 10.1097/00003246-200009000-00008.CrossRefPubMed Aouifi A, Piriou V, Bastien O, Blanc P, Bouvier H, Evans R, Celard M, Vandenesch F, Rousson R, Lehot JJ: Usefulness of procalciton for diagnosis of infection in cardiac surgical patients. Crit Care Med. 2000, 28: 3171-3176. 10.1097/00003246-200009000-00008.CrossRefPubMed
28.
go back to reference Nylen ES, Al Arifi A, Becker KL, Snider RH, Alzeer A: Effect of classic heatstroke on serum procalcitonin. Crit Care Med. 1997, 25: 1362-1365. 10.1097/00003246-199708000-00024.CrossRefPubMed Nylen ES, Al Arifi A, Becker KL, Snider RH, Alzeer A: Effect of classic heatstroke on serum procalcitonin. Crit Care Med. 1997, 25: 1362-1365. 10.1097/00003246-199708000-00024.CrossRefPubMed
29.
go back to reference Remskar M, Horvat M, Hojker S, Noc M: Procalcitonin in patients with acute myocardial infarction. Wien Klin Wochenschr. 2002, 114: 205-210.PubMed Remskar M, Horvat M, Hojker S, Noc M: Procalcitonin in patients with acute myocardial infarction. Wien Klin Wochenschr. 2002, 114: 205-210.PubMed
30.
go back to reference Fries M, Kunz D, Gressner AM, Rossaint R, Kuhlen R: Procalcitonin serum levels after out-of-hospital cardiac arrest. Resuscitation. 2003, 59: 105-109. 10.1016/S0300-9572(03)00164-3.CrossRefPubMed Fries M, Kunz D, Gressner AM, Rossaint R, Kuhlen R: Procalcitonin serum levels after out-of-hospital cardiac arrest. Resuscitation. 2003, 59: 105-109. 10.1016/S0300-9572(03)00164-3.CrossRefPubMed
31.
go back to reference Wilson DJ, Fischer A, Das K, Goerlitz F, Holland BK, De la Torre A, Merchant A, Seguel J, Samanta AK, Koneru B: Donors with cardiac arrest: improved organ recovery but no preconditioning benefit in liver allograft. Transplantation. 2003, 75: 1683-1687. 10.1097/01.TP.0000064542.63798.6B.CrossRefPubMed Wilson DJ, Fischer A, Das K, Goerlitz F, Holland BK, De la Torre A, Merchant A, Seguel J, Samanta AK, Koneru B: Donors with cardiac arrest: improved organ recovery but no preconditioning benefit in liver allograft. Transplantation. 2003, 75: 1683-1687. 10.1097/01.TP.0000064542.63798.6B.CrossRefPubMed
Metadata
Title
Procalcitonin in liver transplantation: are high levels due to donors or recipients?
Authors
Daniel Eyraud
Saïd Ben Ayed
Marie Laure Tanguy
Corinne Vézinet
Jean Michel Siksik
Maguy Bernard
Sylvia Fratéa
Marie Movschin
Jean-Christophe Vaillant
Pierre Coriat
Laurent Hannoun
Publication date
01-08-2008
Publisher
BioMed Central
Published in
Critical Care / Issue 4/2008
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc6942

Other articles of this Issue 4/2008

Critical Care 4/2008 Go to the issue